AKT1 and cancer: As biomarkers, in oesophageal cancers, previous studies have detected 19/29 (65.5%) PIK3R1-positive cancers [49] and considerable variation in constitutively activated AKT (25–90%) in cancer tissues compared with normal tissue [36, 50, 51].